The National Institute of Dental and Craniofacial Research announced a new funding opportunity for scientists to conduct research on the Pharmacogenomics of Orofacial Pain Management (RO1) http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-16-001.html
Pharmacogenomics is the study of how variations in the human genome affect the response to medications. The TMJA is excited about this because it's the first opportunity for scientists to tailor medications specifically targeting the different molecular profiles of TMD patients.
Additional NIH grant opportunties for TMD research are listed on our website.
©2015 The TMJ Association, Ltd. All rights